BridgeBio Pharma Inc. (1BBIO)
MTA
57.71
0.00 (0.00%)
Real-time Data
07:00 AM
Day's Range
57.7157.71
52 wk Range
42.1380.42
Financial Statements - 1BBIO - BridgeBio Pharma Inc.
Revenue
502.07M▲ 167.3%
Net Income
-732.93M▼ 59.3%Net Margin -146.0%
EBITDA
-506.32M▼ 2.9%
Free Cash Flow
-455.50M▼ 1.6%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Sales | 502.07M | 187.86M |
| Cost of Goods | 20.96M | 3.28M |
| Gross Profit | 481.11M | 184.57M |
 Operating Expense | - | - |
| Operating Income | -502.06M | -488.79M |
| Non-Operating Interest | - | - |
| Other Income Expense | -72.05M | 99.23M |
| Pre Tax Income | -732.50M | -459.02M |
| Income Tax | 435K | 976.12K |
| Net Income | -732.93M | -459.99M |
| EPS Basic | -3.78 | -2.88 |
| EPS Diluted | -3.78 | -2.88 |
| Basic Shares Outstanding | 191.52M | 157.53M |
| Diluted Shares Outstanding | 191.52M | 157.53M |
| Ebit | -554.26M | -374.96M |
| Ebitda | -506.32M | -491.95M |
| Net Income Continuous Operations | -732.93M | -459.99M |
| Minority Interests | 8M | 7.58M |
| Preferred Stock Dividends | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
